Navigation Links
Resverlogix Phase 1b/2a Study Meets Primary Endpoint
Date:8/25/2009

family reasons. Due to Mr. McNeill's important contributions to the ongoing corporate development of Resverlogix the Board of Directors in conjunction with Mr. McNeill have agreed to nominate Mr. McNeill as a corporate director at the upcoming October 15th, 2009 Annual General Meeting. Mr. McNeill's promotion to the Board of Directors is a welcome addition that will allow the corporation to continue to benefit from Mr. McNeill's in depth knowledge of Resverlogix and its upcoming corporate development plans.

Resverlogix has recently published one paper in a chemistry publication, Tetrahedron 2009, 65, 6932. Resverlogix will continue to publish a series of research papers demonstrating Resverlogix's understanding of the ability to induce the expression of the Apo A1 gene by small molecules.

Two new important papers have been added to the Resverlogix corporate web site. The first is a detailed White Paper describing Resverlogix understanding of the Reverse Cholesterol Transport system and the Company's targeted goals of reducing the Percent Atheroma Volume (PAV) plaque build up in the arterial wall. The second paper is an abstract of a recently completed Pharmacoeconomics study showing the potential economic impact of being able to reduce the PAV as it relates to the impact on the overburdened US health system. These articles can be found at http://www.resverlogix.com/media/fact_sheets.html.

About RVX-208

RVX-208, a novel small molecule therapeutic that facilitates endogenous ApoA-I production, is positioned to be one of the most promising emerging drugs in the treatment of atherosclerosis. To the Company's knowledge RVX-208 is the only novel small molecule that is specifically designed to increase ApoA-I production and thereby raise HDL levels thus enhancing HDL functionality to augment reverse cholesterol transpor
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Resverlogixs Success in Inflammation Program Results in 2 Patents Filed
2. Resverlogix Provides Quarterly Update
3. Resverlogix Board of Directors Update
4. Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
5. Resverlogix Announces Closing of Debt Redemption
6. Resverlogix Eliminates Sixty Percent of Remaining Debt
7. Resverlogix Issues a Management Statement
8. Resverlogix Board of Directors Update
9. Resverlogix Notice of Conference Call & Webcast
10. Jan Gray Joins Resverlogix Board of Directors
11. Resverlogixs Lead Drug Featured in Key Scientific Publication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, yet many do ... Similar to the liver, or heart, the skin must be ... Recent reports from the mankatofreepress.com explained how caring for the ... other life supporting organs. The article suggests several types of ... the appearance of skin, and fight off acne causing factors. ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... LONDON , June 18, 2013 /PRNewswire/ ... leading international investment research firm, announces the ... (BIO.PA), a French biopharmaceutical company developing and ... supportive care indications.      (Logo: ... a comprehensive report examining the investment merits ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... Feb. 26 Biomerix Corporation announced today that it ... clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), ... ingrowth and can be utilized in a variety of ... hernias. With more than 700,000 procedures per year, inguinal ...
... Feb. 26 ThermoGenesis, Corp. (Nasdaq: KOOL ), ... and store adult stem cells, said today that the FDA ... of certain lots of AXP disposable bagsets that it announced ... recall was not the result of any safety issues; the ...
... SOPHIA ANTIPOLIS, France, February 26 NicOx,S.A. (NYSE ... for,full year 2008 and provided an overview of ... investigational,drug for the treatment of the signs and ... Michele Garufi, Chief Executive Officer of NicOx, ...
Cached Biology Technology:Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 2Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 4Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 5Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 6Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 7Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 8Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 9Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 10Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 11Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 12Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 13Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 14Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 15
(Date:6/17/2013)... in patients with severe brain infections in Vietnam. Further ... responsible for the symptoms of disease. , The virus ... 644 patients with severe brain infections in the study, ... the 122 patients with non-infectious brain disorders that were ... system are often fatal and patients who do survive, ...
(Date:6/17/2013)... in Wayne State University,s Department of Physics kicked ... Experience for Undergraduates (REU) program. This program aims ... research in astrophysics, and in particle and nuclear ... professor of physics in Wayne State,s College of ... of the grant, the student participants will work ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
Breaking Biology News(10 mins):New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3Wayne State welcomes undergraduates from around the US for physics research experience 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... genetic screening (PGS) has been one,of the most hotly ... years. None of the trials,carried out so far has ... European Society of Human,Reproduction and Embryology (ESHRE) Task Force ... if a novel,method of doing PGS using polar body ...
... signal molecule made by the human body that triggers the ... according to new research published today in Nature Medicine ... say that if scientists could block this signal, it may ... arthritis is the most common autoimmune disease, affecting around 1 ...
... fans are in awe of what their football heroes can ... remains strangely mysterious. Although being in excellent physical condition undoubtedly ... can turn an average bloke into a Ronaldo. Now, scientists ... this "something else" might be. Dr. Robbie Wilson will talk ...
Cached Biology News:ESHRE launches international study of polar body screening 2New trigger for chronic inflammation in rheumatoid arthritis discovered 2What makes a great footballer? 2
... frozen Sf9 Insect Cells are derived from the ... for optimal growth, use in transfections, plaque assays, ... frozen in a protocol that optimizes recovery of ... growth in serum-free BacVector Insect Cell Medium and ...
... software package that provides crystallographers with ... buffer creation, set-up of experimental conditions ... The software helps crystallographers through the ... crystallography: Design of ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit can be ...
Biology Products: